Co.-DiagnosticsCODX

13F holders, Q1 2026 (March 31)
14holders +12
11new positions
0sold out
$1.86avg. 13F price*

At the end of Q1 2026, 14 institutions reported holding Co.-Diagnostics Inc. (CODX) in their 13F filings, up 12 from Q4 2025. 11 opened new positions and 0 sold out. The largest holders were Private Advisory Group LLC ($77K), UBS Group AG ($14K) and Smartleaf Asset Management LLC ($226).

Company
Co.-Diagnostics Inc.
CUSIP
189763204
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q4 2025: 2Q4 2025Q1 2026: 14Q1 2026Q2 2026: 24Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions11$91K
Exits0$0

All 13F filers, Q4 2025 → Q1 2026: 49,133 shares bought and 1,847 shares sold, net +47,286 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 14 holders

Private Advisory Group LLC 0.01% New 41,387 $77K
UBS Group AG 0.00% New 7,368 $14K
Smartleaf Asset Management LLC 0.00% New 133 $226
Morgan Stanley 0.00% New 88 $164
Wells Fargo & Company 0.00% New 81 $151
SBI Securities Co., Ltd. 0.00% Reduce -95.8% 58 $108
JPMorgan Chase & Co. 0.00% New 50 $85
Heritage Wealth Advisors 0.00% Reduce -96.8% 17 $32
Osaic Holdings, Inc. 0.00% New 10 $18
Danske Bank A/S 0.00% New 7 $13
NewEdge Advisors, LLC 0.00% New 6 $11
Harbour Investments, Inc. 0.00% New 2 $4
Citigroup Inc. 0.00% New 1 $2
Vanguard Fiduciary Trust Co. 0.00% — 1 $2

"% of holder's portfolio" is CODX's weight in each manager's 13F, not the share of Co.-Diagnostics Inc. the manager owns.